From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza.

Sun Y, Kunanusorn P, Tup KM, Chokkakula S, Yang B

Open source

DOI
10.3389/fcimb.2026.1859541
Published
2026
Container
Frontiers in cellular and infection microbiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcimb.2026.1859541,
  title = {From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza.},
  author = {Sun Y and Kunanusorn P and Tup KM and Chokkakula S and Yang B},
  year = {2026},
  journal = {Frontiers in cellular and infection microbiology},
  doi = {10.3389/fcimb.2026.1859541},
  url = {https://doi.org/10.3389/fcimb.2026.1859541}
}

RIS

TY  - JOUR
TI  - From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza.
AU  - Sun Y
AU  - Kunanusorn P
AU  - Tup KM
AU  - Chokkakula S
AU  - Yang B
PY  - 2026
JO  - Frontiers in cellular and infection microbiology
DO  - 10.3389/fcimb.2026.1859541
UR  - https://doi.org/10.3389/fcimb.2026.1859541
ER  - 

APA

Y, S., P, K., KM, T., S, C., & B, Y. (2026). From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza.. Frontiers in cellular and infection microbiology. https://doi.org/10.3389/fcimb.2026.1859541

Source records